Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|August 1, 1996
Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography eraT E Merchant, M H Wang, T Haida, et al.
Journal of Pain and Symptom Management|June 28, 2000
The measurement of symptoms in children with cancerJ J Collins, M E Byrnes, I J Dunkel, et al.
The Journal of Pediatrics|March 4, 1999
Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlatesJ J Collins, I J Dunkel, S K Gupta, et al.
Journal of Neuro-Oncology|April 3, 1998
High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors. Children's Cancer GroupI J Dunkel, J H Garvin, S Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Myeloablative chemotherapy with autologous bone marrow rescue in young children with recurrent malignant brain tumorsS Guruangan, I J Dunkel, S Goldman, et al.
Medical and Pediatric Oncology|December 7, 2000
Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8K Kramer, N K Cheung, J L Humm, et al.
AJNR. American Journal of Neuroradiology|April 4, 2020
Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor ConsortiumS Vajapeyam, D Brown, C Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 1998
High-dose carboplatin, thiotepa, and etoposide with autologous stem-cell rescue for patients with recurrent medulloblastoma. Children's Cancer GroupI J Dunkel, J M Boyett, A Yates, et al.
Bone Marrow Transplantation|August 5, 2000
High-dose carmustine, thiotepa and etoposide followed by autologous bone marrow rescue for the treatment of high risk central nervous system tumorsV Papadakis, I J Dunkel, L D Cramer, et al.
Ophthalmic Genetics|July 23, 1999
Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastomaD H Abramson, C M Frank, G L Chantada, et al.
Pageof 4